Data / Form D filings / Island Pharmaceuticals Ltd
Island Pharmaceuticals Ltd: Form D filing
Island Pharmaceuticals Ltd, a biotechnology company in Camberwell, Australia, filed a Form D with the SEC in 2024. The latest, on June 5, 2024, reports $1.2 million sold of a $1.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- SUITE 201, 697 BURKE ROAD, Camberwell, Australia, 3124
- Phone
- 61390920475
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Australia
- Year incorporated
- 2020
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2012855
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2024 | New notice | $1,224,405 | $1,224,405 | 4 | Mar 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nick McCoy | Executive Officer | |
| David Foster | Director | |
| David Brookes | Director | |
| Paul MacLeman | Director | |
| Albert Hansen | Director |
Every Form D from the week of Jun 3, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Island Pharmaceuticals Ltd reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.